Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | CAO | April 02, 2025 | April 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date April 02, 2025 · Filed April 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,445 |
Reported balance
After 2025-04-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-04-02 · Sale · Disposed 76 · Balance 42,445 F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2: Includes 34,742 previously reported restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
F2: Includes 34,742 previously reported restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2025 Filed Apr 4, 2025 20:23 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 76 | $15.74 | $1,196.24 |
DisclosureSEC source: 0000950170-25-051156 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,445 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 34,742 previously reported restricted stock units. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 296 | $16.60 | $4,913.60 |
DisclosureSEC source: 0000950170-25-042687 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,521 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 35,034 previously reported restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,731 | $0.00 Strike: $16.98 | $0.00 |
DisclosureSEC source: 0000950170-25-033627 · ownership.xml · derivative · entry 2 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,731 Underlying: Common Stock · 8,731 shares Expires 2032-03-03 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,681 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-033627 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,817 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. F2 · balance_after: Includes 32,565 previously reported restricted stock units. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 187 | $18.08 | $3,380.96 |
DisclosureSEC source: 0000950170-25-014490 · ownership.xml · nonDerivative · entry 2 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,136 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 32,565 previously reported restricted stock units. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 767 | $17.79 | $13,644.93 |
DisclosureSEC source: 0000950170-25-014490 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,323 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 32,565 previously reported restricted stock units. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:27 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 227 | $17.14 | $3,891.21 |
DisclosureSEC source: 0000950170-25-005366 · ownership.xml · nonDerivative · entry 2 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,090 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.27, inclusive. F3 · balance_after: Includes 35,639 previously reported restricted stock units. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:27 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 248 | $16.83 | $4,173.99 |
DisclosureSEC source: 0000950170-25-005366 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,317 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.525 to $17.08, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · balance_after: Includes 35,639 previously reported restricted stock units. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:24 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 238 | $16.97 | $4,039.29 |
DisclosureSEC source: 0000950170-25-004182 · ownership.xml · nonDerivative · entry 2 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,565 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.74 to $17.115, inclusive. F3 · balance_after: Includes 37,206 previously reported restricted stock units. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:24 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 238 | $17.14 | $4,078.18 |
DisclosureSEC source: 0000950170-25-004182 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,803 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.97 to $17.66, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · balance_after: Includes 37,206 previously reported restricted stock units. Read SEC document |
| December 17, 2024 Filed Dec 19, 2024 21:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 26 | $17.84 | $463.84 |
DisclosureSEC source: 0000950170-24-138470 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,041 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 38,758 previously reported restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:27 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 70 | $14.06 | $984.20 |
DisclosureSEC source: 0000950170-24-041107 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,772 F1 · balance_after: Includes 38,859 previously reported restricted stock units. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:38 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,381 | $0.00 Strike: $13.74 | $0.00 |
DisclosureSEC source: 0000950170-24-033563 · ownership.xml · derivative · entry 2 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,381 Underlying: Common Stock · 8,381 shares Expires 2031-03-15 F2 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:38 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,639 | $13.74 | $49,999.86 |
DisclosureSEC source: 0000950170-24-033563 · ownership.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,842 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 23:24 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,967 | $0.00 Strike: $13.29 | $0.00 |
DisclosureSEC source: 0001209191-24-001272 · doc4.xml · derivative · entry 3 Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,967 Underlying: Common Stock · 10,967 shares Expires 2031-01-08 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 23:24 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,703 | $13.29 | $62,502.87 |
DisclosureSEC source: 0001209191-24-001272 · doc4.xml · nonDerivative · entry 2 Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,385 F2 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. F1 · balance_after: Includes 31,423 previously reported unvested restricted stock units. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 23:24 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 459 | $12.67 | $5,815.53 |
DisclosureSEC source: 0001209191-24-001272 · doc4.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,682 F1 · balance_after: Includes 31,423 previously reported unvested restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:31 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 24 | $12.12 | $290.88 |
DisclosureSEC source: 0001209191-23-059160 · doc4.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,141 F1 · balance_after: Includes 32,974 previously reported unvested restricted stock units. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 21:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 23,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052981 · doc4.xml · nonDerivative · entry 1 Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,074 F1 · shares: Represents time-based vesting restriced stock units that vest in full on the second anniversary of grant date. F2 · balance_after: Includes 9,743 previously reported restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.